Moreover, shedding of the invasion-relevant substrate MET via the protease ADAM8 was found to facilitate resistance to TMZ in glioblastoma cells [65]; however, the possible underlying mechanism associated with this soluble MET molecule remains unclear. The gene discussed is MET; the disease is glioblastoma.